FDA Urged to Clarify Voluntary Quality Standards for Combination Products

Drug Industry Daily
A A
A trade group representing combination drug products is urging the FDA to draw bright lines among the agency’s centers as it considers voluntary quality standards.

To View This Article:

Login

Subscribe To Drug Industry Daily